Keywords: fda, panel, reviews, lymerix, safety, food, drug

FDA panel reviews LYMErix safety

Article | 01 February 2001

Print This

A US Food and Drug Administration advisory panel has reviewed the safetyof GlaxoSmithKline's lyme disease vaccine LYMErix, which has been ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in